Ligne de temps

Véronique Mayau
Technicien(ne)
01 janv. 2023
publication

Sec61 blockade therapy overrides resistance to proteasome inhibitors and immunomodulatory drugs in multiple myeloma.

Lire plus
07 mars 2022
publication

The Sec61 translocon is a therapeutic vulnerability in multiple myeloma.

Lire plus
11 janv. 2022
news

New publication – The Sec61 translocon is a therapeutic vulnerability in multiple myeloma

Lire plus
24 déc. 2021
publication

De novo synthesized polyunsaturated fatty acids operate as both host immunomodulators and nutrients for Mycobacterium tuberculosis.

Lire plus
24 sept. 2020
publication

Dysregulation of tryptophan catabolism at the host-skin microbiota interface in Hidradenitis Suppurativa.

Lire plus